MichaelNNeelyMDMSc

PubMed

• Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy.
  Venugopalan, V., Maranchick, N., Hanai, D., Hernandez, Y., Joseph, Y., Gore, A., Desear, K., Peloquin, C., Felton, T., Shoulders, B., Alshaer, M., Neely, M.> ;JAC-Antimicrobial Resistance. 2024 Feb 1
• Time-dependent pharmacodynamics of amikacin ongrowth and resistance emergence.
  Gibson, J., Nandanwar, N., Neely, M.> ;Microbiology Spectrum. 2024 Feb 6
• 4 citations
  Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).
  Thomas J Sferra, Tomas Merta, Michael Neely, Claudia Murta de Oliveira, Alvaro Lassaletta, Claudia Fortuny Guasch, Mary Beth Dorr, Gregory Winchell, Feng-Hsiu Su, Sara...> ;Journal of the Pediatric Infectious Diseases Society. 2023 Jun 30
• Variation in Treatment of Pediatric Tuberculosis Infection in Different Provider Settings.
  Sanchi Malhotra, Shom Dasgupta-Tsinikas, Josephine Yumul, Kelli Kaneta, Annika Lenz, Richard Kizzee, Dustin Bihm, Christina Jung, Michael Neely, Ramon E Guevara, Julie...> ;The Journal of Pediatrics. 2023 Aug 1
• 1 citations
  Isavuconazole Pharmacokinetics and Pharmacodynamics in Children.
  Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael N Neely> ;Pharmaceutics. 2022 Dec 26
• 1 citations
  A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization.
  J D Otalvaro, W M Yamada, A M Hernandez, A F Zuluaga, R Chen, M N Neely> ;Journal of Pharmacokinetics and Pharmacodynamics. 2023 Feb 1
• 2 citations
  Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
  Christopher A Darlow, Laura McEntee, Adam Johnson, Nicola Farrington, Jennifer Unsworth, Ana Jimenez-Valverde, Bhavana Jagota, Ruwanthi Kolamunnage-Dona, Renata M A Da...> ;The Journal of Antimicrobial Chemotherapy. 2022 Nov 28
• 1 citations
  Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients.
  Sumith K Mathew, Shoma V Rao, Ratna Prabha, Michael N Neely, Binu Susan Mathew, Blessed Winston Aruldhas, Balaji Veeraraghavan, Subramani Kandasamy> ;Journal of Clinical Pharmacology. 2023 Jan 1
• 1 citations
  Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.
  Roxane Rohani, Marc H Scheetz, Helen K Donnelly, Alvaro Donayre, Mengjia Kang, Estefani Diaz, Kay Dedicatoria, Alan R Hauser, Egon A Ozer, Sophia Nozick, Chao Qi, Anna...> ;The Journal of Antimicrobial Chemotherapy. 2022 Oct 28
• 1 citations
  Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients.
  Silke Gastine, Georg Hempel, Michael N Neely, Thomas J Walsh, Andreas H Groll> ;The Journal of Antimicrobial Chemotherapy. 2022 Jul 28
• 8 citations
  Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics.
  Mohammad H Alshaer, Sylvain Goutelle, Barbara A Santevecchi, Bethany R Shoulders, Veena Venugopalan, Kartikeya Cherabuddi, Jiajun Liu, Patrick J Kiel, Jason A Roberts,...> ;Antimicrobial Agents and Chemotherapy. 2022 Feb 15
• 14 citations
  Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug...
  Stephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, Sara Baldelli, Dario Cattaneo, Graham Jones, Birgit C P Koch, Danijela Kocic, Sumith K Mathew, Mariadelfi...> ;Therapeutic Drug Monitoring. 2022 Feb 1
• 5 citations
  Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.
  Sarah Kim, Arnold Louie, George L Drusano, Mohammed Almoslem, Soyoung Kim, Jenny Myrick, Jocelyn Nole, Brandon Duncanson, Charles A Peloquin, Charles A Scanga, Walter ...> ;International Journal of Antimicrobial Agents. 2022 Feb 1
• 2 citations
  Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients.
  Femke de Velde, Brenda C M de Winter, Michael N Neely, Jan Strojil, Walter M Yamada, Stephan Harbarth, Angela Huttner, Teun van Gelder, Birgit C P Koch, Anouk E Muller...> ;Pharmaceutics. 2021 Dec 16
• 9 citations
  Parametric and Nonparametric Methods in Population Pharmacokinetics: Experts' Discussion on Use, Strengths, and Limitations.
  Sylvain Goutelle, Jean-Baptiste Woillard, Thierry Buclin, Laurent Bourguignon, Walter M. Yamada, Chantal Csajka, Michael Neely, Monia Guidi> ;Journal of Clinical Pharmacology. 2021 Oct 28
• 4 citations
  Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence.
  Nishant Nandanwar, Joy E. Gibson, Michael Neely> ;Microbiological Research. 2021 Oct 5
• 2 citations
  A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapy
  Gellért Karvaly, István Karádi, István Vincze, Michael Neely, Eszter Trojnár, Zoltán Prohászka, Éva Imreh, Barna Vásárhelyi, András Zsáry> ;Pharmacology Research & Perspectives. 2021 Oct 1
• 7 citations
  Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships.
  Marc H. Scheetz, Gwendolyn M Pais, Thomas P. Lodise, Steven Y. C. Tong, Joshua S. Davis, J. Nicholas O'Donnell, Jiajun Liu, Michael Neely, Walter C. Prozialeck, Peter ...> ;Antimicrobial Agents and Chemotherapy. 2021 Aug 2
• 3 citations
  Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase.
  Sarah Kim, Walter M. Yamada, Brandon Duncanson, Jocelyn Nole, Stephanie Rogers, Sarah Parker, Meredith Bacci, Nino Mtchedlidze, Charles A. Peloquin, Arnold Louie, Step...> ;Antimicrobial Agents and Chemotherapy. 2021 Aug 2
• 4 citations
  To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
  Sylvain Goutelle, Céline Alloux, Laurent Bourguignon, Michael Van Guilder, Michael Neely, Pascal Maire> ;Therapeutic Drug Monitoring. 2021 Aug 1
• 80 citations
  Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy.
  Kaidi He, Wendy J. Mack, Michael Neely, Laura Lewis, Vikram Anand> ;Journal of Community Health. 2021 Jul 23
• VP Shunt With Recurrent Malfunction in Two Pediatric Patients: Is the Hydrocephalus Truly Idiopathic?
  Mimi R. Precit, Cynthia Enriquez, Michael Neely, Michael A. Smit, Jeffrey M. Bender, Jennifer Dien Bard, Vikram Anand, Sindhu Mohandas> ;The Pediatric Infectious Disease Journal. 2021 Jul 13
• 7 citations
  The case for precision dosing: medical conservatism does not justify inaction.
  Marc H. Scheetz, Thomas P. Lodise, Kevin J. Downes, George L. Drusano, Michael Neely> ;The Journal of Antimicrobial Chemotherapy. 2021 Jun 18
• 15 citations
  Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
  Antonio Arrieta, Michael Neely, J. Christopher Day, Susan R. Rheingold, Paul K. Sue, William J Muller, Lara Danziger-Isakov, Julie Chu, Inci Yildirim, Grace A. McComse...> ;Antimicrobial Agents and Chemotherapy. 2021 May 24
• 3 citations
  Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics.
  Jennifer Le, Michael Neely, Nicolás Cortés-Penfield, John S. Bradley, Michael J. Rybak, Nathaniel J. Rhodes, Avedissian, S. N., Sean N. Avedissian> ;The Journal of Antimicrobial Chemotherapy. 2021 Aug 12
• Join now to see all

Journal Articles

• Maximal Concentration of Intravenous Busulfan as a Determinant of Veno-Occlusive Disease: A Pharmacokinetic-Pharmacodynamic Analysis in 293 Hematopoietic Stem Cell Tra...  
  Michael Neely, MD, Nature
• Quantification of alendronate in diseased jaw bone of patients with bisphosphonate-­‐related jaw osteonecrosis by energy dispersive x-­‐ray spectroscopy.  
  Schaudinn C, Gorur A, Webster P, Jones AC, Neely MN, Jelliffe RW, Le AD, Sedghizadeh PP, Oral Surg Oral Med Oral Pathol
• High Dose of Darunavir in Treatment­ ‐ experienced HIV ‐ infected Adolescent Results in Virologic Suppression and Improved CD4 Count.  
  Rakhmanina N, Neely MN, Capparelli EV, Ther Drug Monit;34(3):237-­?241
• Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir In HIV positive and Healthy Individuals.  
  Arab-­Alameddine M, Fayet-­Mello A, Lubomirov R, Neely MN, di Iulio J, Boffito M, Owen A, Cavassini M, Guethard H, Rentsch K, Buclin T, Aouri M, Telenti A, Decosterd L..., Antimicrob Agents Chemother;56(6):2959-­?66
• More Codeine Fatalities After Tonsillectomy in North American Children.  
  Kelly L, Rieder M, van den Anker J, Malkin B, Ross C, Neely MN, Carleton B, Hayden, M, Parvaz M, Koren G, Pediatrics;129(5):e1343-­?7
• Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.  
  Nicolas C, Neely MN, Bourguignon L, Maire P, Jelliffe R, Goutelle S, Antimicrob Agents Chemother;56(4):1862-­?9
• Cervical pap screening cytological abnormalities among HIV-­‐ infected adolescents in the LEGACY cohort.  
  Setse R, Siberry GK, Moss WJ, Gravitt P, Wheeling T, Bohannon B, Dominguez K, J Pediatr Adolesc Gynecol;25(1):27-­?34
• Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2-­‐ to 10-­‐year-­‐old human immunodeficiency virus-­‐infected children.  
  Siberry GK, Warshaw MG, Williams PL, Spector SA, Decker MD, Jean-­?Philippe P, Yogev R, Heckman BE, Manzella A, Roa J, Nachman S, Lujan-­?Zilbermann J; IMPAACT P1065 P..., Pediatr Infect Dis J;31(1):47-­?52
• Posaconazole for chronic refractory coccidioidal meningitis.  
  Schein R, Homans J, Larsen RA, Neely MN, Clin Infect Dis;53(12):1252-­?4
• Associations of medically documented psychiatric diagnoses and risky health behaviors in highly active antiretroviral therapy-­‐ experienced perinatally HIV-­‐infected...  
  Kapetanovic S, Wiegand RE, Dominguez K, Blumberg D, Bohannon B, Wheeling J, Rutstein R; LEGACY Consortium, AIDS Patient Care STDS;25(8):493-­?501
• Nonparametric population modeling and Bayesian analysis.  
  Jelliffe R, Neely MN, Schumitzky A, Bayard D, Van Guilder M, Botnen A, Bustad A, Laing D, Yamada W, Bartroff J, Tatarinova T, Pharmacol Res. 23
• First-­‐line antiretroviral therapy with a protease inhibitor versus non-­‐nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV...  
  PENPACT-­?1 (PENTA 9/PACTG 390) Study Team, Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, M..., Lancet Infect Dis;11(4):273-­?83
• Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.  
  Malee K, Williams P, Montepiedra G, McCabe M, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B, AIDS Patient Care STDS;25(3):191-­?200
• Mode of delivery and infant respiratory morbidity among infants born to HIV-­‐1-­‐infected women.  
  Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, Bardeguez A, Stek A, Read JS, . Obstet Gynecol;116(2 Pt 1):335-­?43
• Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-­‐infected children 7 to 12 years old.  
  Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA 3rd, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A; IMPAACT P1047 Protocol Team, J Acquir Immune Defic Syndr.1;55(2):197-­?204
• Phase I/II, open-­‐label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-­‐135) polysaccharide diphtheria toxoid conjugate vaccine in human ...  
  Siberry GK, Williams PL, Lujan-­?Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-­?Philippe P, Kabat W, Nachman S; IMPAACT P1065 ..., Pediatr Infect Dis J;29(5):391-­?6
• Can TDM improve pharmacotherapy of HIV infection in adolescents?  
  Rakhmanina N, van den Anker JN, Soldin SJ, van Schaik RH, Mordwinkin N, Neely MN, Ther Drug Monit;32(3):273-­?81
• Neurodevelopment and in utero antiretroviral exposure of HIV-­‐exposed uninfected infants.  
  Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM, Pediatrics;125(2):e250-­?60
• Seven “Pillars of Wisdom” for maximally precise therapeutic drug management.  
  Jelliffe R, Neely MN, Klin Farmakol Farm;24(1):7-­?10
• Human genetic variation, population pharmacokinetic – dynamic models, Bayesian feedback control, and maximally precise individualized drug dosage regimens.  
  Jelliffe R, Schumitzky A, Bayard D, Leary R, Botnen A, Van Guilder M, Bustad A, Neely M, Current Pharmacogenomics and Personalized Medicine; 7: 249-­?262
• The use of second-­‐ generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.  
  Kapetanovic S, Aaron L, Montepiedra G, Sirois PA, Oleske JM, Malee K, Pearson DA, Nichols SL, Garvie PA, Farley J, Nozyce ML, Mintz M, Williams PL, AIDS Patient Care STDS;23(11):939-­?47
• Impact of medications prescribed for treatment of attention-­‐deficit hyperactivity disorder on physical growth in children and adolescents with HIV.  
  Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA, Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, Oleske JM, J Dev Behav Pediatr30(5):403-­?12
• Impact of HAART and CNS-­‐penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.  
  Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team, AIDS;23(14):1893-­?901
• Incidence of noninfectious conditions in perinatally HIV-­‐infected children and adolescents in the HAART era.  
  Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team, Arch Pediatr Adolesc Med;163(2):164-­?71
• The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.  
  Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, Kammerer B; PACTG 219C Team, J Pediatr Psychol;34(2):164-­?75
• Join now to see all

Books/Book Chapters

• Principles and Practices of Pediatric Infectious Diseases. 
  Chapter: The Pharmacokinetic-­?Pharmacodynamic Basis of Optimal Antibiotic Dosing 
  Neely MN, Reed MDEditors: S. Long, L. Pickering, C. Prober.Edition 4,
• Principles and Practices of Pediatric Infectious Diseases. 
  Chapter: The Pharmacokinetic-­?Pharmacodynamic Basis of Optimal Antibiotic Dosing 
  Neely MN, Reed MDEditors: S. Long, L. Pickering, C. Prober.Edition 3,
• The Mycota, A Comprehensive Treatise on Fungi as Experimental Systems for Basic and Applied Research: Vol. XII, Studies of Human Fungal Pathogens for the New Millennium. 
  Chapter: New Azoles 
  Neely MN, Ghannoum MAEditors: G. Kobayashi, J. Domer.
• Principles and Practices of Pediatric Infectious Diseases. 
  Chapter: The Pharmacokinetic-­?Pharmacodynamic Basis of Optimal Antibiotic Dosing 
  Neely MN, Reed MDEditors: S. Long, L. Pickering, C. Prober.Edition 2,
• Join now to see all

Abstracts/Posters

• Mathematical Modeling of Ceftazidime for High-­‐Flux Hemodialysis Patients.
  Loo A, Neely MN, Anderson E, Ghossein C, Griffith M, Scheetz M, 2nd Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco, CA
• Population PK-­‐ PD of bisphosphonate (BP)-­‐related osteonecrosis of the jaw (BRONJ).
  Sedghizadeh PP, Le AD, Lee P, Kiss A, Jones A, Jelliffe RW, Neely MN, American College of Clinical Pharmacology Annual Meeting, San Diego, CA
• A. Non-­‐parametric Bayesian fitting: a novel approach to population pharmacokinetic modeling.
  Neely MN, Tatarinova T, Bartroff J, van Guilder M, Yamada W, Bayard D, Jelliffe RW, Schumitzky A, 21st Population Approach Group in Europe meeting, Venice, Italy
• Software to enable optimally precise dosage adjustment of voriconazole to achieve predefined serum concentration targets in critically patients.
  Hope W, Van Guilder M, Donnelly P, Blijlevens N, Bruggemann R, Jelliffe R, Neely MN, 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, England
• Comparison of four renal function estimator-­‐based models for the prediction of gentamicin concentrations in geriatric patients by use of nonparametric population app...
  Charhon N, Bourguignon L, Maire P, Jelliffe RW, Neely MN, Goutelle S, 20th Population Approach Group in Europe meeting, Athens, Greece
• Maturation of glucuronidation; a system specific property.
  Krekels EHJ, Panoilia E, Neely MN, Tibboel D, Capparelli E, Danhof M, Mirochnick M, Knibbe CAJ, 20th Population Approach Group in Europe meeting, Athens, Greece
• Tenofovir Population Pharmacokinetics in Children and Adults.
  Neely MN, Mordwinkin M, Goicoechea M, Louie S, Jelliffe R, van den Anker J, Rakhmanina N, 12th International Workshop on HIV Pharmacology, Miami, FL
• Zidovudine Glucuronidation in Premature and Term Infants.
  Neely MN, Kovacs A, Mirochnick M, Capparelli E, American Conference on Pharmacometrics, San Diego, CA
• Experience with CMX001, a novel antiviral drug for adenovirus infections in immunocompromised patients.
  Florescu DF, Rigdon J, Pergam SA, Neely MN, Johnston C, Way SS, Sande J, Lewinsohn D, Guzman-­?Cottrill J, Kurtzberg J, Papanicolaou G, Graham ML, Painter W, Lanier R..., 48th annual meeting of the Infectious Diseases Society of America, Vancouver
• Exposure to nucleoside-­‐reverse transcriptase inhibitors and fasting lipid profiles in HIV-­‐infected children.
  Rakhmanina NY, van Miltenburg M, van den Anker J, Soldin S, Williams K, Neely MN, 2nd International Workshop on HIV Pediatrics, Vienna, Austria
• High-­‐dose amoxicillin pharmacokinetics and pharmacodynamics in children.
  Neely MN, Reed MD, Jelliffe RW, 19th Population Approach Group in Europe meeting, Berlin, Germany
• Pharmacogenomics and individualized dose regimens.
  Jelliffe RW, Neely MN, Ozdemir V, 19th Population Approach Group in Europe meeting, Berlin, Germany
• The MM-­‐USCPACK software for nonparametric adaptive grid (NPAG) population PK/PD modeling, and the MM-­‐USCPACK clinical software for individualized drug regimens.
  Jelliffe RW, Schumitzky A, Bayard D, Leary R, van Guilder M, Neely MN, Goutelle S, Bustad A, Khayat M, Thomson A, 19th Population Approach Group in Europe meeting, Berlin, Germany
• Antiretroviral regimen and pharmacogenomic determinants of tenofovir-­‐associated change in creatinine clearance in ACTG protocol A5142.
  Goicoechea M, Zheng Y, Hughes M, Riddler S, Neely MN, Haas D, Louie S, Haubrich R, 18th International AIDS Conference, Vienna, Austria
• Plasma protease inhibitor concentrations and fasting lipid profiles in HIV-­‐infected children.
  Rakhmanina N, van den Anker J, Scott M, Soldin S, Williams K, Neely MN, 11th HIV Pharmacology Workshop, Sorrento, Italy
• Effect of Lopinavir/Ritonavir on Lipids in HIV-­‐infected Children.
  Rakhmanina N, van den Anker J, Scott M, Soldin S, Williams K, Neely MN, 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA
• Safety and Efficacy of NRTI-­‐only Antiretroviral Regimens (NOARs) in HIV-­‐infected Children.
  Neely M, Rutstein R, del Bianco G, Heresi G, Barton T, Wheeling J, Wiegand R, Bohannon B, Dominguez K, Wiznia, 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA
• Morphine pharmacokinetics in sickle cell disease: implications for pain management.
  Darbari D, Neely MN, van den Anker J, Rana S, Annual Meeting of the American Society of Hematology, New Orleans
• Pharmacokinetics of once daily raltegravir and atazanavir in healthy volunteers.
  Neely MN, Decosterd L, Fayet A, Lee J, Margol A, Kanani M, von Schoen Angerer T, Jelliffe R, Calmy A, 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa
• Voriconazole Population Pharmacokinetics and Pharmacodynamics in Children.
  Neely MN, Rushing T, Kovacs A, Jelliffe R, Hoffman J, 18th Population Approach Group in Europe meeting, Moscow, Russia
• The Phenotypic and Genotypic Susceptibility Lopinavir Scores and Virologic Response in Treatment-­‐Experienced Children with HIV.
  Rakhmanina N, van den Anker J, Baghdassarian A, Soldin S, Williams K, Neely MN, 10th HIV Pharmacology Workshop, Amsterdam
• Atazanavir concentrations in plasma, breast milk and vaginal secretions of HIV-­‐infected women.
  Neely MN. Spencer L, Mordwinkin N, Leon T, Louie S, Jelliffe R, Kovacs A, 10th HIV Pharmacology Workshop, Amsterdam
• Intensive Pharmacokinetics of Zidovudine, Lamivudine, and Atazanavir and HIV-­‐ 1 Viral Load in Breast Milk and Plasma in HIV+ Women Receiving HAART.
  Spencer L, Neely M, Mordwinkin N, Leon T, Fredericks T, Karim R, Louie S, Kovacs A, 16th Conference on Retroviruses and Opportunistic Infections (CROI)
• Pharmacometric tools to optimize drug therapy.
  Jelliffe RW, Schumitzky A, Bayard D, Leary R, Thomson A, Botnen A, Neely MN, Quantitative & Systems Pharmacology Workshop, National Institutes of Health, Bethesda, MD
• Antiviral therapy induces viral and clinical response in patients with central nervous system dysfunction and chromosomally integrated Human Herpesvirus-­‐6.
  Kar1 AK, Lunn MR, Neely MN, Ambros PF, Troy SB, Montoya JG, 6th International Conference on HHV-­?6 & 7
• Join now to see all

Lectures

• Pharmacometric tools for optimally precise individualized drug therapy: non-­‐ parametric population modeling, multiple-­‐model Bayesian adaptive control and optimal a... 
  American College of Clinical Pharmacology 38th Annual meeting, San Antonio, TX
• Non-­‐parametric Pharmacokinetic Modeling. 
  Department of Haematology, Jagiellonian University, Krakow, Poland
• Individualizing Drug Dosage regimens. How to do it with graphical software at the Bedside or Nurses’ Station. 
  Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Buenos Aires, Argentina
• Individualized Dosing – How to do it at the bedside or nurse’s station. 
  American College of Clinical Pharmacology 39th Annual meeting, Baltimore, MD
• Clinical Pharmacometrics. 
  National Children’s Hospital, Washington DC
• Pertussis. 
  Neonatal M&M Conference, Methodist Hospital, Arcadia, CA
• Personalized Medicine and Individualized Doses. 
  Clinical Pharmacology Unit, Christian Medical College, Vellore, India
• Bayesian adaptive control of antimicrobial therapy: Getting the dose right in the 21st Century. 
  Emerging Pathogens Institute, University of Florida, Gainesville
• Multiple Model Adaptive Control – Getting the Dose Right in the 21st Century. 
  American Conference on Pharmacometrics, San Diego, CA
• Pediatric HIV Case Presentations. 
  12th HIV Pharmacology Workshop, Miami
• Does one size fit all? Getting the dose right in the 21st century. 
  Pediatric Grand Rounds, Los Angeles County – University of Southern California Medical Center
• Practical individualized dosing: 21st century therapeutics and the clinical pharmacometrician. 
  12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germa
• Getting the dose right in the 21st century. 
  Department of Pediatrics, University of Alabama at Birmingham
• Using R and PMETRICS for non-­‐parametric population PK modeling and simulation. 
  Division of Clinical Pharmacology, University of Alabama at Birmingham
• What’s So Hard About Vancomycin? Getting the Dose Right in the 21st Century. 
  Infectious Diseases Grand Rounds, Harbor-­?UCLA Medical Center, Torrance, CA
• Introduction to parametric and non-­‐parametric population modeling using R. 
  Advanced Pharmacokinetics, USC School of Pharmacy, Los Angeles, CA
• What’s So Hard About Vancomycin? Getting the Dose Right in the 21st Century. 
  Maternal Child Adolescent Center for Infectious Diseases and Virology, LAC+USC Medical Center, Los A
• Population modeling: assay errors, covariate analysis, and continued introduction to programming in R. 
  PSCI599 – Advanced Pharmacokinetics, USC School of Pharmacy, Los Angeles, CA
• Clinical Pharmacometrics: Getting the dose right in the 21st century. 
  USC School of Pharmacy, Los Angeles, CA
• An Introduction to Non-­‐Parametric Population PK Modeling and Simulation Using the R Package Pmetrics. 
  School of Medicine and Pharmacy, Rockefeller Campus, Lyon, France
• Vertical Transmission of HIV: How Are We Doing at Rainbow? 
  NICU Conference, University Hospitals of Cleveland
• Candida and Catheters. 
  PICU Management Conference, University Hospitals of Cleveland
• Pharmacology of Anti-­‐fungal Drugs. 
  World Wide Web International Pediatric Chat
• Drug Hypersensitivity Reactions. 
  Pediatric Management Conference, University Hospitals of Cleveland
• New Antibiotics. 
  Pediatrics Today Conference, University Hospitals of Cleveland
• Join now to see all

Other

• Pharmacokinetics and pharmacodynamics of once daily raltegravir and atazanavir in healthy volunteers. Master’s Thesis. 
  Neely MN, University of Southern California
  http://digitallibrary.usc.edu
• How to complete an overseas elective. 
  Neely MN, Resident Report
  American Academy of Pediatrics
• Amblyopia and vernier acuity. 
  Neely MN, Senior honors thesis
  U.C. Berkeley